Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Parisi, Richard
REVITALYZ, NCT06525077: Safety and Efficacy of FT218 in Idiopathic Hypersomnia	Recruiting	3	150	US	FT218, LUMRYZ, Placebo	Avadel	Idiopathic Hypersomnia	02/26	09/26
NCT05668754: Placebo-Controlled, Double-Blind, Study to Determine the Safety and Efficacy of SDX in Patients With IH	Completed	2	50	US	Serdexmethylphenidate, SDX, Placebo	Zevra Therapeutics, Rho, Inc.	Idiopathic Hypersomnia	02/24	03/24